MilliporeSigma Receives Patent for CRISPR Technology in China Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells Company to license CRISPR-related patents to interested parties, supports genome-editing research under ethical and legal standards Foundational CRISPR patents now granted in seven markets, including Canada and Europe Burlington, Massachusetts, April... Read more
One-day event in Beijing convened more than 400 leaders from government, academia and industry to discuss precision medicine advancement BEIJING, March 29, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today sponsored the first China-U.S. Precision Medicine Summit, along with co-hosts CEO Roundtable on Cancer, China Academy of Medical Sciences and... Read more
28th March 2018 Microsaic Systems PLC (LON:MSYS), the developer of point of need mass spectrometry (“MS”) instruments, has today announced that it has signed an agreement with Unimicro Technologies Inc. (“Unimicro”)(the “Agreement”). The Agreement covers the integration of Microsaic’s compact 4500 MiD® mass spectrometry detector with Unimicro’s Capillary Electrophoresis (“CE”) Platform. Once integrated, the combined product will be... Read more
— Establishing a global laboratory structure covering nine locations in five countries — Shanghai, China, March 20, 2018—Hitachi High-Technologies (Shanghai) Co., Ltd., a Chinese subsidiary of Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announces that it has opened “Hitachi High-Tech Science Park Shanghai Lab” (Shanghai Lab) in Shanghai, China on June 20, 2018 to promote... Read more
Location: Cambridge 16/03/2018 Partnership immediately provides Horizon with deeper access to Chinese diagnostic assay manufacturers and potential OEM agreements as part of stated global leadership strategy Genewell to pursue CFDA approval of Horizon reference standards for broad distribution into Chinese clinical laboratory market Cambridge, UK, and Shenzhen, China, 16 March 2018: Horizon Discovery Group plc... Read more
MilliporeSigma and Schneider Electric combine capabilities to automate biopharmaceutical process Customers would save time, get greater flexibility with automated solution Shanghai, China, March 5, 2018 — MilliporeSigma, a leading science and technology company, and Schneider Electric, a global specialist in energy management and automation, announced the signing of a Memorandum of Understanding (MoU) that aims to automate... Read more
Sphere Fluidics Signs Single Cell Technology Corporation to be Their Distributor in China and Taiwan. by Sphere Fluidics | Jan 22, 2018 | News Read more
Leading Diagnostics Companies Combine to Address Diagnostic and Wellness Testing in China November 13, 2017 04:00 AM Pacific Standard Time FRAMINGHAM, Mass. & SHANGHAI–(BUSINESS WIRE)–SCIEX Diagnostics, the in vitro diagnostics (IVD) division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that it has formed a joint venture (JV) with Zhejiang... Read more
– Long-read, real-time DNA and RNA sequencing now available to researchers and clinical scientists through China’s preeminent and most comprehensive CLIA/CAP laboratory – WuXi NextCODE partners can now combine nanopore sequencing and the world’s leading informatics to solve genomics challenges with the potential to improve health SHANGHAI, CAMBRIDGE, Mass. and REYKJAVIK, Iceland, Oct. 17, 2017 /PRNewswire/ — WuXi NextCODE,... Read more
Thu 12th October 2017 中文版 October 2017: Oxford Nanopore sequencing technology is now available in China. The long-read, real-time, portable MinION sequencer is now being used by researchers across China, who are working on myriad DNA sequencing applications including: pathogen research, human genetics, plant genetics, animal genetics and metagenomics. Chinese researchers are also preparing to start cDNA and... Read more